SNEHA CAMPANELLA: Open Payments
NPI 1679778963 · WELLESLEY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 8 payments from 7 companies in 2025. Trend: 2023 $31 · 2024 $116 · 2025 $225
Food & beverage: $158Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $91 |
| GENZYME CORPORATION | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $16 |
| LNHC, Inc | 1 | $14 |
Products named: TREMFYA, DUPIXENT, OPZELURA, Cabtreo, AKLIEF, ZELSUVMI.
Industry payments across MA — which companies pay providers there.
